MENU
NAMS
AS OF
Dec 24 closing price
Price
$35.65
Change
-$0.30 (-0.83%)
Capitalization
4.04B
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NewAmsterdam Pharma (NAMS) Ownership - Who owns NewAmsterdam Pharma?

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.04B
P/E Ratio
N/A
Total Cash
702.95M
Projected Growth
N/A
Total Debt
266K
Revenue
35.24M
Risk (Beta)
0.17
Dividend Yield
N/A
Total Cash/Share
6.20
Total Debt/Equity
N/A
Revenue/Share
0.31 USD as % of share price

Fundamentals

NAMS
Capitalization
4.04B
P/E Ratio
N/A
Risk (Beta)
0.17
Dividend Yield
N/A
Total Cash
703M
Total Cash/Share
6.20
Total Debt
266K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.31%
Revenue
35.2M
ROE
N/A
Book Value
728M
P/B Ratio
5.55
Cash Flow
N/A
Earnings
-2.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14.1M
Current Ratio
12.57
Current Revenue Per Employee
4519.48
Dividends Per Share - Security
N/A
EBITDA
-268.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.08
Shares Held By Institutions
4.92B
Shares Outstanding - Current
113M
Total Liabilities
58.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
38.716
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NAMS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAMS showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NAMS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com